Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing
Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing MUMBAI, India, Dec 23, 2020 /PRNewswire/ -- Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Menarini Group (Menarini) for commercializing its innovative nasal spray Ryaltris™ across 33 countries in Europe, including t...
Source: uniindia.com